This study aims to understand the impact of anaesthesia on duration of disease free survival in patients undergoing surgery for colorectal or non-small cell lung cancer.
This trial is treating patients with colorectal cancer or non-small cell lung cancer.
This is a surgical trial.
You may be able to join this trial if:
- Your cancer has not spread to other parts of the body.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
- You have been diagnosed with a prior or secondary type of cancer.
- You have had certain treatments, surgical procedures or drugs.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.
Clinical Summary Read More
Use the hyperlinks, where available to access additional clinical trial information.
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: The VAPOR-C Trial
Other Non-Commercial Sponsor
Peter MacCallum Cancer Centre
This trial is testing the superiority of propofol (total intravenous anaesthesia -TIVA) over sevoflurane (inhalational volatile anaesthesia) and intravenous lidocaine over placebo in patients undergoing surgery for colorectal or non small cell lung cancer (NSCLC). Eligible participants will be randomly allocated to one of four treatment arms.
Recruiting Hospitals Read More
Not Recruiting Hospitals Read More